QS-21

Basic structure of QS-21, consisting of a quillaic acid triterpene (black) substituted with a branched trisaccharide (blue) and a linear tetrasaccharide (green), which is in turn connected to an acyl chain (red) via a hydrolytically labile ester. QS-21 is a 65:35 mixture of the Apiose- and the Xylose-substituted variants of above molecule.

QS-21 is a chromatographic purified fraction out of a plant extract used as a vaccine adjuvant. It is derived from the soap bark tree (Quillaja saponaria), which is native of Chile. The crude drug (Quillajae cortex, Quillaia) is extracted and purified form imported bark coming from Chile.

The extract contains water-soluble triterpene glycosides, which are members of a family of plant-based compounds called saponins. It has been tested as an adjuvant in various vaccines in attempts to improve their efficacy. It enhance both humoral and cell-mediated immunity.

Use

QS-21 has been clinically evaluated as a vaccine adjuvant. As of 2002, it had been tested in more than 3000 patients in 60 clinical trials.

Direct, unencapsulated QS-21 is considered toxic. It also causes immediate pain at injection site and, in vitro, causes hemolysis. All of these can be prevented by packaging QS-21 into lipid-based particles, which also have the added advantage of targeting its delivery to phagocytes. It is part of: